Bio-Rad Laboratories Class A
354 hedge funds and large institutions have $6.43B invested in Bio-Rad Laboratories Class A in 2019 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 148 increasing their positions, 97 reducing their positions, and 29 closing their positions.
86% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 29
53% more repeat investments, than reductions
Existing positions increased: 148 | Existing positions reduced: 97
10% more capital invested
Capital invested by funds: $5.87B → $6.43B (+$562M)
7% more funds holding
Funds holding: 330 → 354 (+24)
2.26% more ownership
Funds ownership: 75.91% → 78.17% (+2.3%)
36% less funds holding in top 10
Funds holding in top 10: 11 → 7 (-4)
69% less call options, than puts
Call options by funds: $9.75M | Put options by funds: $31.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$121M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$96.4M |
| 3 |
BlackRock
New York
|
+$48.4M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$37M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$34.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIP
Easterly Investment Partners
Beverly,
Massachusetts
|
-$120M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$61.1M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$47.9M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$28.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$26.6M |
BIO Hedge Fund Activity: Q3 2019 in Review
354 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2019, worth a combined $6.43B — up 9.6% from $5.87B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new BIO positions and 29 closed out — a net gain of 25 holders — while 148 added to existing stakes and 97 trimmed.
The largest buyer was Acadian Asset Management, opening a new position worth an estimated $121M. The largest seller was Easterly Investment Partners, cutting an estimated $120M.
- 354 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2019, up from 330 in Q2 2019.
- Funds reported $6.43B of Bio-Rad Laboratories Class A stock for Q3 2019, up 9.6% quarter-over-quarter.
- 54 funds opened new Bio-Rad Laboratories Class A positions in Q3 2019 and 29 closed out, a net change of +25 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q3 2019 was Acadian Asset Management, an estimated $121M added.
- The largest Bio-Rad Laboratories Class A seller in Q3 2019 was Easterly Investment Partners, an estimated $120M sold.
Based on aggregated 13F filings for Q3 2019.